Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEWCL Biomedical Laboratory is a premier clinical laboratory in Taiwan providing a wide range of advanced bio-testing services, including hepatitis B (HBV), hepatitis C (HCV), genotype, and allergen chip testing. In 2025, it partnered with Gene Solutions to establish an advanced NGS laboratory in New Taipei City, bringing next-generation prenatal and oncology genetic tests to patients across Taiwan. This partnership is expected to accelerate the adoption of precision medicine in Taiwan, making advanced genetic testing more accessible and cost-effective compared to previous reliance on overseas laboratories. NEWCL serves major hospitals and medical service units throughout Taiwan and is part of the DITECH Enterprise group[4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEWCL Biomedical Laboratory.